Psychedelics
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
47
NCT06702332
Single Ascending Dose Study of MSD-001 in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 11, 2024
Completion: Jul 11, 2025
Loading map...